Cboe BZX · PCL
PGIM Corporate Bond 10+ Year ETF financials
$45.76−1.06%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '14 Dec 31 | Q3 '14 Sep 30 | Q2 '14 Jun 30 | Q1 '14 Mar 31 | Q4 '13 Dec 31 | Q3 '13 Sep 30 | Q2 '13 Jun 30 | Q1 '13 Mar 31 | Q4 '12 Dec 31 | Q3 '12 Sep 30 | Q2 '12 Jun 30 | Q1 '12 Mar 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $410.0M | $375.0M | $356.0M | $317.0M | $331.0M | $366.0M | $303.0M | $340.0M | $354.0M | $354.0M | $294.0M | $337.0M |
| Gross profit | $101.0M | $109.0M | $109.0M | $85.0M | $98.0M | $122.0M | $90.0M | $110.0M | $127.0M | $110.0M | $81.0M | $78.0M |
| Gross margin | 24.6% | 29.1% | 30.6% | 26.8% | 29.6% | 33.3% | 29.7% | 32.4% | 35.9% | 31.1% | 27.6% | 23.1% |
| Operating income | $68.0M | $86.0M | $79.0M | $56.0M | $64.0M | $94.0M | $61.0M | $78.0M | $97.0M | $79.0M | $54.0M | $50.0M |
| Net income | $68.0M | $61.0M | $55.0M | $30.0M | $40.0M | $72.0M | $46.0M | $56.0M | $79.0M | $59.0M | $36.0M | $29.0M |
| Net margin | 16.6% | 16.3% | 15.4% | 9.5% | 12.1% | 19.7% | 15.2% | 16.5% | 22.3% | 16.7% | 12.2% | 8.6% |
| Diluted EPS | $0.39 | $0.34 | $0.31 | $0.17 | $0.24 | $0.44 | $0.28 | $0.35 | $0.49 | $0.36 | $0.22 | $0.18 |
| EBITDA | $105.0M | $121.0M | $113.0M | $88.0M | $64.0M | $129.0M | $86.0M | $104.0M | $97.0M | $110.0M | $83.0M | $77.0M |
| Operating cash flow | $135.0M | $133.0M | $132.0M | $57.0M | $84.0M | $180.0M | $139.0M | $1.0M | $116.0M | $148.0M | $83.0M | $6.0M |
| Free cash flow | $111.0M | $108.0M | $108.0M | $41.0M | $64.0M | $160.0M | $122.0M | -$13.0M | $96.0M | $131.0M | $66.0M | -$12.0M |
| Diluted shares | 177.0M | 177.1M | 177.4M | 177.3M | 165.0M | 163.4M | 163.4M | 162.8M | 161.9M | 161.9M | 161.7M | 161.7M |
Balance sheet
| Period end | Dec 31 | Sep 30 | Jun 30 | Mar 31 | Dec 31 | Sep 30 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $92.0M | $90.0M | $107.0M | $104.0M | $433.0M | $439.0M |
| Short-term investments | — | — | — | — | — | — |
| Total debt | $2.51B | $2.57B | $2.57B | $2.59B | $2.90B | $2.40B |
| Total assets | $5.19B | $5.28B | $5.34B | $5.35B | $5.70B | $4.63B |
| Total liabilities | $3.52B | $3.57B | $3.57B | $3.57B | $3.07B | $3.40B |
| Shareholders' equity | $1.67B | $1.70B | $1.77B | $1.79B | $2.62B | $1.23B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology